A detailed history of Deutsche Bank Ag\ transactions in Castle Biosciences Inc stock. As of the latest transaction made, Deutsche Bank Ag\ holds 309,511 shares of CSTL stock, worth $8.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
309,511
Previous 262,808 17.77%
Holding current value
$8.62 Million
Previous $5.82 Million 15.75%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$18.84 - $24.94 $879,884 - $1.16 Million
46,703 Added 17.77%
309,511 $6.74 Million
Q1 2024

May 15, 2024

BUY
$18.06 - $25.3 $1.93 Million - $2.71 Million
106,978 Added 68.65%
262,808 $5.82 Million
Q4 2023

Feb 14, 2024

BUY
$12.19 - $22.43 $1.73 Million - $3.18 Million
141,792 Added 1010.06%
155,830 $3.36 Million
Q3 2023

Nov 09, 2023

BUY
$13.28 - $20.3 $42,190 - $64,493
3,177 Added 29.25%
14,038 $237,000
Q2 2023

Aug 14, 2023

SELL
$11.66 - $26.0 $50,954 - $113,620
-4,370 Reduced 28.69%
10,861 $149,000
Q1 2023

May 15, 2023

BUY
$19.47 - $28.49 $84,421 - $123,532
4,336 Added 39.8%
15,231 $346,000
Q4 2022

Feb 13, 2023

BUY
$18.08 - $30.0 $2,928 - $4,860
162 Added 1.51%
10,895 $256,000
Q3 2022

Nov 14, 2022

SELL
$22.51 - $34.32 $11,480 - $17,503
-510 Reduced 4.54%
10,733 $280,000
Q2 2022

Aug 11, 2022

SELL
$16.0 - $45.99 $16,144 - $46,403
-1,009 Reduced 8.24%
11,243 $247,000
Q1 2022

May 13, 2022

SELL
$33.17 - $46.98 $51,678 - $73,194
-1,558 Reduced 11.28%
12,252 $549,000
Q4 2021

Feb 11, 2022

SELL
$39.06 - $67.58 $352,477 - $609,841
-9,024 Reduced 39.52%
13,810 $592,000
Q3 2021

Nov 04, 2021

BUY
$60.13 - $77.6 $448,690 - $579,051
7,462 Added 48.54%
22,834 $1.52 Million
Q2 2021

Aug 11, 2021

BUY
$50.07 - $76.78 $183,156 - $280,861
3,658 Added 31.23%
15,372 $1.13 Million
Q1 2021

May 13, 2021

BUY
$58.92 - $97.33 $81,486 - $134,607
1,383 Added 13.39%
11,714 $801,000
Q4 2020

Feb 16, 2021

BUY
$43.6 - $73.05 $54,761 - $91,750
1,256 Added 13.84%
10,331 $693,000
Q3 2020

Nov 12, 2020

BUY
$38.47 - $52.03 $154,457 - $208,900
4,015 Added 79.35%
9,075 $467,000
Q2 2020

Aug 13, 2020

BUY
$27.28 - $43.01 $47,112 - $74,278
1,727 Added 51.82%
5,060 $191,000
Q1 2020

May 14, 2020

BUY
$23.08 - $35.53 $46,598 - $71,735
2,019 Added 153.65%
3,333 $99,000
Q4 2019

Feb 14, 2020

BUY
$15.74 - $35.04 $4,580 - $10,196
291 Added 28.45%
1,314 $44,000
Q3 2019

Nov 14, 2019

BUY
$18.09 - $27.92 $18,506 - $28,562
1,023 New
1,023 $16,000

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $733M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.